Skinbiotherapeutics (SBTX)

Company name:	Skinbiotherapeutics Plc
Company Description:	SkinBioTherapeutics is a life science company focused on skin health.
EPIC:	SBTX	Trading Currency:	GBX
Market Sector:	AMQ1	ISIN:	GB00BF33H870
Market Segment:	ASQ1	Share Type:	DE
WWW Address:	http://www.skinbiotherapeutics.com/	Description:	ORD 1P
Industry Sector:	PHARMACEUTICALS & BIOTECHNOLOGY

Skinbiotherapeutics Key Figures

(at previous day's close)
Market Cap.	20.18	m
Shares In Issue	118.71	m
Prev. Close	17.00
PE Ratio	-
Dividend Yield	-	%
EPS - basic	-0.94	p
Dividend PS	-	p
Dividend Cover	-
Cash Flow PS	-1.20	p
Return On Equity (ROE)	-30.13	%
Operating Margin	-	%
PEG Factor	-
EPS Growth Rate	-32.39	%
Dividends PS Growth Rate	-	%
Net Debt	-3.00	m
Gross Gearing	3.09	%
Quick Assets	3.58	m
Net Working Capital	3.46	m
Intangibles / Fixed Assets	98.08	%
Turnover PS	-	p
Pre-Tax Profit PS	-1.15	p
Retained Profit PS	-0.97	p
Cash PS	2.63	p
Net Cash PS	2.53	p
Net Tangible Asset Value PS *	2.92	p
Net Asset Value PS	3.21	p
Spread	1.00 (5.71%)
* Calculation based on Ordinary Capital figure as contained in last annual report, and the most recent shares in issue figure. Therefore the ratio might be exposed to inaccuracies.

Period ^†	Open	Change	%	Open Avg.	Avg. Daily Vol [m]	Total Vol [m]	VWAP
1 week	17.00	-	-	16.25	0.97		17.09
4 weeks	18.00	-1.00	-5.56	16.25	0.70		18.01
12 weeks	19.75	-2.75	-13.92	16.25	0.55		20.99
26 weeks	10.88	6.13	56.32	10.13	0.73		18.24
1 year	18.50	-1.50	-8.11	5.75	0.59		15.50
3 years	10.50	6.50	61.90	5.75	0.40		16.24
5 years	13.25	3.75	28.30	5.75	0.41		15.61
† periods calculated are whole weeks rather than calendar months

(Market value analysis) at previous day's close
PQ Ratio	-
PE Ratio	-
Tobin's Q Ratio	5.32
Tobin's Q Ratio (excl. intangibles)	5.81
Dividend Yield	-	%
Market-to-Book Ratio	5.30
Price-to-Pre-Tax Profit PS	-14.83
Price-to-Retained Profit PS	-17.58
Price-to-Cash Flow PS	-14.13
Price-to-Sales PS	-
Price-to-Net Tangible Asset Value PS	5.83
Price-to-Cash PS	6.46
Net Working Capital PS	2.91
Price Pct to Working Capital PS	5.84	%
Earnings Yield	-	%
Average PE	-
Years in average	-
PE to PE average	-	%

(Leverage Ratios)
Debt Ratio	-	%
Debt-to-Equity Ratio	-
Debt-to-Equity Ratio (excl. Intgbl)	-
Debt-to-Equity Market Value	-
Net Gearing	-76.40	%
Net Gearing (excl. Intangibles)	-83.79	%
Gross Gearing	3.09	%
Gross Gearing (excl. Intangibles)	3.38	%
Gearing Under 1 Year	3.09	%
Gearing Under 1 Year (excl. Intgbl)	3.38	%
Assets/Equity	1.03
Cash/Equity	82.01
(Liquidity Ratios)
Net Working Capital to Total Assets	87.92	%
Current Ratio	29.49
Quick Ratio (Acid Test)	29.49
Liquidity Ratio	25.75
Cash & Equiv/Current Assets	87.34	%
(Solvency Ratios)
Enterprise Value	17.06	m
CFO/Sales	-
CFO/Attributable Profit	-
CFO/Assets	-0.36
CFO/Debt	-11.77
Total Debt/Equity Market Value	0.01
Total Debt/Sales	-
Total Debt/Pre-Tax Profit	-0.09
Total Debt	0.12	m
Total Debt/Net Current Assets	0.04	%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth	-5.39	%
5 yr Compound Earnings Growth	-	%
10 yr Compound Earnings Growth	-	%
Earn drops > 5% in 10yrs	1

Beta (60-Mnth)	Beta (36-Mnth)
-0.0013	-0.0001

(Profitability Ratios)
Return On Capital Employed (ROCE)	-35.71	%
Return On Assets (ROA)	-30.29	%
Net Profit Margin	-	%
Assets Turnover	-
Return On Equity (ROE)	-30.13	%
Return On Investment (ROI)	-31.67	%
Dividend Payout Ratio	-	%
Plowback Ratio	100.00	%
Growth from Plowback Ratio	-	%
Net Income Of Revenues	-	%
(Asset Utilisation Multiples)
Shareholders Equity Turnover	-
Fixed Assets Turnover	-
Current Assets Turnover	-
Net Working Capital Turnover
Inventory Turnover	-
(Other Operating Ratios)
Total Assets-to-Sales	-
Debtors-to-Sales	-	%
Debt Collection Period	-	Days

Sorry No Data Available

Broker infomation is not available for this class of stock.